Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jul 30, 2025
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $39.00 as of August 1, 2025.
Market Cap
39.00
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has decreased from 27.10K to 39.00, a decrease of -99.86%. That is a compound annual growth rate of -50.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 39.00 | -98.99% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | 10.86M | 312.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |
| CytoDyn | 357.98M |